Herpes simplex virus type 2 infection of human epithelial cells induces CXCL9 expression and CD4 + T cell migration via activation of p38-CCAAT/enhancer-binding protein-β pathway

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 6247-6257

  Huang, Wenjie ^a   Hu, Kai ^a,b   Luo, Sukun ^a,b   Zhang, Mudan ^a,b   Li, Chang ^a,b   Jin, Wei ^a,b   Liu, Yalan ^a   Griffin, George E ^c   Shattock, Robin J ^d   Hu, Qinxue ^a,c  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; CCAAT ENHANCER BINDING PROTEIN GAMMA; CCAAT ENHANCER BINDING PROTEIN SIGMA; CXCL9 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL LINE; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEXUAL TRANSMISSION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; UPREGULATION; UTERINE CERVIX EPITHELIUM; UTERINE CERVIX MUCUS;

ADULT; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CD4-POSITIVE T-LYMPHOCYTES; CERVIX UTERI; CHEMOKINE CXCL9; CHEMOTAXIS, LEUKOCYTE; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; YOUNG ADULT;

EID: 84862607224     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103706     Document Type: Article

References (54)

1. Van de Perre, P., M. Segondy, V. Foulongne, A. Ouedraogo, I. Konate, J. M. Huraux, P. Mayaud, and N. Nagot. 2008. Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect. Dis. 8: 490-497. (Pubitemid 352005823)
2. Koelle, D. M., and L. Corey. 2008. Herpes simplex: insights on pathogenesis and possible vaccines. Annu. Rev. Med. 59: 381-395. (Pubitemid 351287944)
3. Gupta, R., T. Warren, and A. Wald. 2007. Genital herpes. Lancet 370: 2127-2137. (Pubitemid 350296304)
4. Chen, C. Y., R. C. Ballard, C. M. Beck-Sague, Y. Dangor, F. Radebe, S. Schmid, J. B. Weiss, V. Tshabalala, G. Fehler, Y. Htun, and S. A. Morse. 2000. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex. Transm. Dis. 27: 21-29. (Pubitemid 30058900)
5. Cunningham, A. L., R. J. Diefenbach, M. Miranda-Saksena, L. Bosnjak, M. Kim, C. Jones, and M. W. Douglas. 2006. The cycle of human herpes simplex virus infection: virus transport and immune control. J. Infect. Dis. 194(Suppl. 1): S11-S18. (Pubitemid 44420867)
6. Freeman, E. E., H. A. Weiss, J. R. Glynn, P. L. Cross, J. A. Whitworth, and R. J. Hayes. 2006. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20: 73-83. (Pubitemid 41818117)
7. Wald, A., and K. Link. 2002. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 185: 45-52. (Pubitemid 34043015)
8. Fakioglu, E., S. S. Wilson, P. M. Mesquita, E. Hazrati, N. Cheshenko, J. A. Blaho, and B. C. Herold. 2008. Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism. J. Virol. 82: 9337-9344.
9. Kwant-Mitchell, A., A. A. Ashkar, and K. L. Rosenthal. 2009. Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model. J. Virol. 83: 10664-10676.
10. de Jong, M. A., L. de Witte, M. E. Taylor, and T. B. Geijtenbeek. 2010. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function. J. Immunol. 185: 1633-1641.
11. Mesquita, P. M., N. Cheshenko, S. S. Wilson, M. Mhatre, E. Guzman, E. Fakioglu, M. J. Keller, and B. C. Herold. 2009. Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety. J. Infect. Dis. 200: 599-608.
12. Rebbapragada, A., C. Wachihi, C. Pettengell, S. Sunderji, S. Huibner, W. Jaoko, B. Ball, K. Fowke, T. Mazzulli, F. A. Plummer, and R. Kaul. 2007. Negative mucosal synergy between herpes simplex type 2 and HIV in the female genital tract. AIDS 21: 589-598.
13. Zhu, J., F. Hladik, A. Woodward, A. Klock, T. Peng, C. Johnston, M. Remington, A. Magaret, D. M. Koelle, A. Wald, and L. Corey. 2009. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 15: 886-892.
14. Martinelli, E., H. Tharinger, I. Frank, J. Arthos, M. Piatak, Jr., J. D. Lifson, J. Blanchard, A. Gettie, and M. Robbiani. 2011. HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. PLoS Pathog. 7: e1002109.
15. Shattock, R. J., and J. P. Moore. 2003. Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 1: 25-34.
16. Hladik, F., and M. J. McElrath. 2008. Setting the stage: host invasion by HIV. Nat. Rev. Immunol. 8: 447-457. (Pubitemid 351735878)
17. Haase, A. T. 2010. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464: 217-223.
18. Salazar-Gonzalez, J. F., M. G. Salazar, B. F. Keele, G. H. Learn, E. E. Giorgi, H. Li, J. M. Decker, S. Wang, J. Baalwa, M. H. Kraus, et al. 2009. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 206: 1273-1289.
19. Ochsenbauer, C., T. G. Edmonds, H. Ding, B. F. Keele, J. Decker, M. G. Salazar, J. F. Salazar-Gonzalez, R. Shattock, B. F. Haynes, G. M. Shaw, et al. 2012. Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J. Virol. 86: 2715-2728.
20. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127. (Pubitemid 30398626)
21. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242.
22. Thapa, M., R. S. Welner, R. Pelayo, and D. J. Carr. 2008. CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. J. Immunol. 180: 1098-1106.
23. Liao, F., R. L. Rabin, J. R. Yannelli, L. G. Koniaris, P. Vanguri, and J. M. Farber. 1995. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182: 1301-1314.
24. Romagnani, P., F. Annunziato, L. Lasagni, E. Lazzeri, C. Beltrame, M. Francalanci, M. Uguccioni, G. Galli, L. Cosmi, L. Maurenzig, et al. 2001. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107: 53-63. (Pubitemid 32047414)
25. Loetscher, M., B. Gerber, P. Loetscher, S. A. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184: 963-969.
26. Howell, A. L., R. D. Edkins, S. E. Rier, G. R. Yeaman, J. E. Stern, M. W. Fanger, and C. R. Wira. 1997. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J. Virol. 71: 3498-3506. (Pubitemid 27172360)
27. Hu, Q., I. Frank, V. Williams, J. J. Santos, P. Watts, G. E. Griffin, J. P. Moore, M. Pope, and R. J. Shattock. 2004. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J. Exp. Med. 199: 1065-1075. (Pubitemid 38619903)
28. Xia, L. M., W. J. Huang, J. G. Wu, Y. B. Yang, Q. Zhang, Z. Z. Zhou, H. F. Zhu, P. Lei, G. X. Shen, and D. A. Tian. 2009. HBx protein induces expression of MIG and increases migration of leukocytes through activation of NF-kappaB. Virology 385: 335-342.
29. Eriksson, K., L. Bellner, S. Görander, G. B. Löwhagen, P. Tunbäck, K. Rydberg, and J. A. Liljeqvist. 2004. CD4(+) T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals. J. Gen. Virol. 85: 2139-2147. (Pubitemid 39172074)
30. Huang, W. J., L. M. Xia, F. Zhu, B. Huang, C. Zhou, H. F. Zhu, B. Wang, B. Chen, P. Lei, G. X. Shen, and D.-A. Tian. 2009. Transcriptional upregulation of HSP70-2 by HIF-1 in cancer cells in response to hypoxia. Int. J. Cancer 124: 298-305.
31. Takenaka, M., A. S. Preston, H. M. Kwon, and J. S. Handler. 1994. The tonicity-sensitive element that mediates increased transcription of the betaine transporter gene in response to hypertonic stress. J. Biol. Chem. 269: 29379-29381. (Pubitemid 24365079)
32. Ghosh, A. K., S. Bhattacharyya, Y. Mori, and J. Varga. 2006. Inhibition of collagen gene expression by interferon-gamma: novel role of the CCAAT/enhancer binding protein beta (C/EBPbeta). J. Cell. Physiol. 207: 251-260.
33. Rasmussen, S. B., S. B. Jensen, C. Nielsen, E. Quartin, H. Kato, Z. J. Chen, R. H. Silverman, S. Akira, and S. R. Paludan. 2009. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene-like receptors, which synergize to induce type I interferon production. J. Gen. Virol. 90: 74-78.
34. Gupta, R., A. Wald, E. Krantz, S. Selke, T. Warren, M. Vargas-Cortes, G. Miller, and L. Corey. 2004. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J. Infect. Dis. 190: 1374-1381. (Pubitemid 39332176)
35. Corey, L., A. Wald, R. Patel, S. L. Sacks, S. K. Tyring, T. Warren, J. M. Douglas, Jr., J. Paavonen, R. A. Morrow, K. R. Beutner, et al Valacyclovir HSV Transmission Study Group. 2004. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N. Engl. J. Med. 350: 11-20. (Pubitemid 38032179)
36. Celum, C., A. Wald, J. Hughes, J. Sanchez, S. Reid, S. Delany-Moretlwe, F. Cowan, M. Casapia, A. Ortiz, J. Fuchs, et al HPTN 039 Protocol Team. 2008. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 371: 2109-2119. (Pubitemid 351902179)
37. Watson-Jones, D., H. A. Weiss, M. Rusizoka, J. Changalucha, K. Baisley, K. Mugeye, C. Tanton, D. Ross, D. Everett, T. Clayton, et al HSV Trial Team; Steering and Data Monitoring Committees. 2008. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N. Engl. J. Med. 358: 1560-1571. (Pubitemid 351519816)
38. Fuchs, J., C. Celum, J. Wang, J. Hughes, J. Sanchez, F. Cowan, S. Reid, S. Delany-Moretlwe, L. Corey, and A. Wald; HIV Prevention Trials Network 039 Protocol Team. 2010. Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial. J. Infect. Dis. 201: 1164-1168.
39. Horton, M. R., S. Boodoo, and J. D. Powell. 2002. NF-kappa B activation mediates the cross-talk between extracellular matrix and interferon-gamma (IFN-gamma) leading to enhanced monokine induced by IFN-gamma (MIG) expression in macrophages. J. Biol. Chem. 277: 43757-43762. (Pubitemid 36157794)
40. Luftig, M., T. Yasui, V. Soni, M. S. Kang, N. Jacobson, E. Cahir-McFarland, B. Seed, and E. Kieff. 2004. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Proc. Natl. Acad. Sci. USA 101: 141-146. (Pubitemid 38084217)
41. Liu, Y., M. R. Nonnemacher, and B. Wigdahl. 2009. CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection. Future Microbiol. 4: 299-321.
42. Lekstrom-Himes, J., and K. G. Xanthopoulos. 1998. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273: 28545-28548. (Pubitemid 28507532)
43. Zahnow, C. A., R. D. Cardiff, R. Laucirica, D. Medina, and J. M. Rosen. 2001. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res. 61: 261-269. (Pubitemid 32095726)
44. Burkart, A. D., A. Mukherjee, E. Sterneck, P. F. Johnson, and K. E. Mayo. 2005. Repression of the inhibin alpha-subunit gene by the transcription factor CCAAT/enhancer-binding protein-beta. Endocrinology 146: 1909-1921. (Pubitemid 40396900)
45. Zhang, N., Q. A. Truong-Tran, B. Tancowny, K. E. Harris, and R. P. Schleimer. 2007. Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins. J. Immunol. 179: 578-589. (Pubitemid 46986575)
46. Venza, I., M. Cucinotta, M. Visalli, G. De Grazia, S. Oliva, and D. Teti. 2009. Pseudomonas aeruginosa induces interleukin-8 (IL-8) gene expression in human conjunctiva through the recruitment of both RelA and CCAAT/enhancer- binding protein beta to the IL-8 promoter. J. Biol. Chem. 284: 4191-4199.
47. Schwartz, C., K. Beck, S. Mink, M. Schmolke, B. Budde, D. Wenning, and K. H. Klempnauer. 2003. Recruitment of p300 by C/EBPbeta triggers phosphorylation of p300 and modulates coactivator activity. EMBO J. 22: 882-892. (Pubitemid 36227790)
48. Koria, P., and S. T. Andreadis. 2007. KGF promotes integrin alpha5 expression through CCAAT/enhancer-binding protein-beta. Am. J. Physiol. Cell Physiol. 293: C1020-C1031. (Pubitemid 47437393)
49. Schindler, J. F., J. B. Monahan, and W. G. Smith. 2007. p38 pathway kinases as anti-inflammatory drug targets. J. Dent. Res. 86: 800-811.
50. Shahabuddin, S., R. Ji, P. Wang, E. Brailoiu, N. Dun, Y. Yang, M. O. Aksoy, and S. G. Kelsen. 2006. CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways. Am. J. Physiol. Cell Physiol. 291: C34-C39.
51. Zhang, Z., J. L. Bryan, E. DeLassus, L. W. Chang, W. Liao, and L. J. Sandell. 2010. CCAAT/Enhancer-binding protein beta and NF-kappaB mediate high level expression of chemokine genes CCL3 and CCL4 by human chondrocytes in response to IL-1beta. J. Biol. Chem. 285: 33092-33103.
52. Sandell, L. J., X. Xing, C. Franz, S. Davies, L. W. Chang, and D. Patra. 2008. Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. Osteoarthritis Cartilage 16: 1560-1571.
53. Marin, V., C. Farnarier, S. Grès, S. Kaplanski, M. S. Su, C. A. Dinarello, and G. Kaplanski. 2001. The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment. Blood 98: 667-673.
54. Cara, D. C., J. Kaur, M. Forster, D. M. McCafferty, and P. Kubes. 2001. Role of p38 mitogen-activated protein kinase in chemokine-induced emigration and chemotaxis in vivo. J. Immunol. 167: 6552-6558. (Pubitemid 33081591)